The activation of PINK1 by small molecules has emerged as a promising strategy in treating Parkinson's disease (PD). Recent progress in this area has raised excitement around PINK1 activators as PD treatments, and herein we offer insight into these developments and their potential to deliver much needed novel PD treatments.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350934 | PMC |
http://dx.doi.org/10.1021/acsmedchemlett.3c00070 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!